Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Correspondence

Correspondence to editorial on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C”

Tom Ryu, Young Chang, Seung Up Kim, Jae Young Jang

Clin Mol Hepatol. 2025;31(2):e203-e205. Published online February 24, 2025

DOI: https://doi.org/10.3350/cmh.2025.0179

View: 440 Download: 15 Crossref: 1

Original Article

Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C

Tom Ryu, Young Chang, Soung Won Jeong, Jeong-Ju Yoo, Sae Hwan Lee, Sang Gyune Kim, Young Seok Kim, Hong Soo Kim, Seung Up Kim, Jae Young Jang

Clin Mol Hepatol. 2025;31(2):548-562. Published online January 9, 2025

DOI: https://doi.org/10.3350/cmh.2024.0904

View: 1070 Download: 98 Crossref: 1

Letter to the Editor

Development of risk scores for prognosis prediction among patients with early-stage hepatocellular carcinoma

Xiping Shen, Ji Wu

Clin Mol Hepatol. 2025;31(1):e17-e18. Published online October 11, 2024

DOI: https://doi.org/10.3350/cmh.2024.0794

View: 1056 Download: 46 Crossref: 1

Review

Histopathological evaluation of liver fibrosis and cirrhosis regression

Regina C. Lo, Haeryoung Kim

Clin Mol Hepatol. 2017;23(4):302-307. Published online December 20, 2017

DOI: https://doi.org/10.3350/cmh.2017.0078

View: 18086 Download: 569 Web of Science: 101 Crossref: 99

Case Report

Regression of esophageal varices and splenomegaly in two patients with hepatitis-C-related liver cirrhosis after interferon and ribavirin combination therapy

Soon Jae Lee, Yoo-Kyung Cho, Soo-Young Na, Eun Kwang Choi, Sun Jin Boo, Seung Uk Jeong, Hyung Joo Song, Heung Up Kim, Bong Soo Kim, Byung-Cheol Song

Clin Mol Hepatol. 2016;22(3):390-395. Published online August 30, 2016

DOI: https://doi.org/10.3350/cmh.2015.0050

View: 11907 Download: 134 Web of Science: 1 Crossref: 2

Editorial

Regression of liver cirrhosis: Orthodoxy or paradigm shift?

Su Jong Yu

Clin Mol Hepatol. 2015;21(1):22-23. Published online March 25, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.1.22

View: 7135 Download: 91 Web of Science: 2 Crossref: 1

4

A Case of Complete Regression of Hepatocellular Carcinoma during Administration of COX-2 Inhibitor

Hae Jung Song, M.D., Yun Soo Kim, M.D. Chang Hee Han, M.D., Jae Young Jang, M.D., Jung Hoon Kim, M.D. Young Koog Cheon, M.D., Young Seok Kim, M.D., Jong Ho Moon, M.D., Young Deok Cho, M.D., Chan Sup Shim, M.D., Kui Hyang Kwon, M.D. and Boo Sung Kim, M.D.

Clin Mol Hepatol. 2006;12(3):449-454. Published online January 1, 2000

View: 2884 Download: 19

1 |

Viewed By 10152	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7215	MAFLD: How is it different from NAFLD?
Viewed By 5205	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4700	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4650	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment

Cited By 322	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 304	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 208	MAFLD: How is it different from NAFLD?
Cited By 104	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
Cited By 103	Non-alcoholic fatty liver disease: Definition and subtypes

Search